Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
MOR-210 by Biogen for Autoimmune Disorders: Likelihood of Approval
MOR-210 is under clinical development by Biogen and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I...